Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab.
Sands
Mark F
MF
Blume
Jessica W
JW
Schwartz
Stanley A
SA
D000368:Aged; D000799:Angioedema / Q000188:drug therapy*; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D012008:Recurrence
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab